These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32274326)

  • 21. Corrigendum to "Harmonization of breast cancer radiotherapy treatment planning in the Netherlands" [Tech. Innov. Patient Support Radiat. Oncol. 19 (2021) 26-32].
    Hurkmans C; Duisters C; Peters-Verhoeven M; Boersma L; Verhoeven K; Bijker N; Crama K; Nuver T; van der Sangen M
    Tech Innov Patient Support Radiat Oncol; 2023 Mar; 25():100196. PubMed ID: 36659912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum to 'Health-Promoting Lifestyle in Colorectal Cancer Survivors: A Qualitative Study on the Experiences and Perspectives of Colorectal Cancer Survivors and Healthcare Providers' [Asia-Pacific J Oncol Nursing 8 (2021) 696-710].
    Ramezanzade Tabriz E; Ramezani M; Heydari A; Aledavood SA
    Asia Pac J Oncol Nurs; 2022 Aug; 9(8):100106. PubMed ID: 35983241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrigendum to "Challenges in the transition to independent radiation oncology practice and targeted interventions for improvement" [Tech. Innov. Patient Support Radiat. Oncol. 24 (2022) 113-117].
    De Leo AN; Drescher N; Bates JE; Yeung AR
    Tech Innov Patient Support Radiat Oncol; 2023 Mar; 25():100202. PubMed ID: 36873801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.
    Oyama R; Kito F; Takahashi M; Sakumoto M; Shiozawa K; Qiao Z; Noguchi R; Kubo T; Toki S; Nakatani F; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2019 Apr; 32(2):202-213. PubMed ID: 30737713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum to "Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance" [Gynecol. Oncol. Rep. 34 (2020) 100648].
    Oh J; Barve M; Senzer N; Aaron P; Manning L; Wallraven G; Bognar E; Stanbery L; Horvath S; Manley M; Nemunaitis J; Walter A; Rocconi RP
    Gynecol Oncol Rep; 2021 May; 36():100740. PubMed ID: 34095420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum to "Surface-guided radiotherapy for lung cancer can reduce the number of close patient contacts without compromising initial setup accuracy" [Tech. Innov. Patient Support Radiat. Oncol. 20 (2021) 61-63].
    Blake N; Pereira L; Eaton DJ; Dobson D
    Tech Innov Patient Support Radiat Oncol; 2023 Mar; 25():100197. PubMed ID: 36659911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dedifferentiated Chondrosarcoma of the Larynx.
    Fidai SS; Ginat DT; Langerman AJ; Cipriani NA
    Head Neck Pathol; 2016 Sep; 10(3):345-8. PubMed ID: 26718693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dedifferentiated chondrosarcoma of bone with prominent rhabdoid component.
    Stemm M; Beck C; Mannem R; Neilson J; Klein MJ
    Ann Diagn Pathol; 2017 Jun; 28():7-11. PubMed ID: 28648942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of a dedifferentiated chondrosarcoma of the pelvis by fine needle aspiration. A case report.
    Estrada-Villaseñor E; Rico-Martínez G; Linares-Gonzalez LM
    Acta Cytol; 2010; 54(2):217-20. PubMed ID: 20391984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dedifferentiated chondrosarcoma revisited.
    Mavrogenis AF; Ruggieri P; Mercuri M; Papagelopoulos PJ
    J Surg Orthop Adv; 2011; 20(2):106-11. PubMed ID: 21838071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is dedifferentiated chondrosarcoma a 'de-differentiated' chondrosarcoma?
    Aigner T; Unni KK
    J Pathol; 1999 Dec; 189(4):445-7. PubMed ID: 10629541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhabdomyosarcomatous component in dedifferentiated chondrosarcoma.
    Niezabitowski A; Edel G; Roessner A; Grundmann E; Timm C; Wuisman P
    Pathol Res Pract; 1987 Apr; 182(2):275-82. PubMed ID: 3601806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532].
    Santin AD; Filiaci V; Bellone S; O'Cearbhaill R; Ratner ES; Mathews CA; Cantuaria G; Gunderson CC; Rutledge T; Buttin BM; Lankes HA; Birrer MJ
    Gynecol Oncol Rep; 2020 Aug; 33():100590. PubMed ID: 32885014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer.
    Katz H; Wassie E; Alsharedi M
    Med Oncol; 2017 Sep; 34(10):170. PubMed ID: 28864844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dedifferentiated chondrosarcoma with leukocytosis and elevation of serum G-CSF. A case report.
    Sakamoto A; Yamamoto H; Tanaka K; Matsuda S; Harimaya K; Oda Y; Tsuneyoshi M; Iwamoto Y
    World J Surg Oncol; 2006 Jul; 4():37. PubMed ID: 16820056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].
    Anract P; Tomeno B; Forest M
    Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):669-80. PubMed ID: 7638395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dedifferentiated chondrosarcoma with rhabdomyosarcomatous differentiation.
    Reith JD; Bauer TW; Fischler DF; Joyce MJ; Marks KE
    Am J Surg Pathol; 1996 Mar; 20(3):293-8. PubMed ID: 8772782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Squamous cell carcinoma arising in dedifferentiated chondrosarcoma proved by isocitrate dehydrogenase mutation analysis.
    Zhang Y; Paz Mejia A; Temple HT; Trent J; Rosenberg AE
    Hum Pathol; 2014 Jul; 45(7):1541-5. PubMed ID: 24792622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fine-needle aspiration of dedifferentiated chondrosarcoma of the larynx.
    Faquin WC; Pilch BZ; Keel SB; Cooper TL
    Diagn Cytopathol; 2000 May; 22(5):288-92. PubMed ID: 10790235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benign looking giant cell component in dedifferentiated chondrosarcoma: benign or malignant? A case report.
    Huang J; Jiang Z; Yang Q; Zhang H
    Int J Surg Pathol; 2013 Feb; 21(1):48-53. PubMed ID: 22736299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.